Samuel Agresta

CIK: 0001748961

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (77.8%)

Compensation grants

Other (G, F, J, C, D, …)2 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OKUR

OnKure Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

OKUR
OnKure Therapeutics, Inc.
Aug 7, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
131.4K shares-
OKUR
OnKure Therapeutics, Inc.
Aug 7, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
50K shares-
OKUR
OnKure Therapeutics, Inc.
Aug 7, 2026
Disposition(D)
Employee Stock Option (right to buy)
Direct
18.6K shares-
OKUR
OnKure Therapeutics, Inc.
Aug 7, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
18.6K shares-
OKUR
OnKure Therapeutics, Inc.
Aug 7, 2026
Disposition(D)
Employee Stock Option (right to buy)
Direct
131.4K shares-
OKUR
OnKure Therapeutics, Inc.
Apr 1, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
110K shares-
OKUR
OnKure Therapeutics, Inc.
Jan 27, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
45K shares-
OKUR
OnKure Therapeutics, Inc.
Oct 4, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
18.6K shares-
OKUR
OnKure Therapeutics, Inc.
Oct 4, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
131.4K shares-

		Type	Shares	Price		Ownership
Aug 7, 2026	OKUR OnKure Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	131,396	-	-	Direct
Aug 7, 2026	OKUR OnKure Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	50,000	-	-	Direct
Aug 7, 2026	OKUR OnKure Therapeutics, Inc.	Disposition(D) Employee Stock Option (right to buy)	18,588	-	-	Direct
Aug 7, 2026	OKUR OnKure Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	18,588	-	-	Direct
Aug 7, 2026	OKUR OnKure Therapeutics, Inc.	Disposition(D) Employee Stock Option (right to buy)	131,396	-	-	Direct
Apr 1, 2026	OKUR OnKure Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	110,000	-	-	Direct
Jan 27, 2025	OKUR OnKure Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	45,000	-	-	Direct
Oct 4, 2024	OKUR OnKure Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	18,588	-	-	Direct
Oct 4, 2024	OKUR OnKure Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	131,396	-	-	Direct

1-9 of 9 transactions

About Agresta Samuel

Agresta Samuel (SEC CIK 0001748961) files insider reports with the SEC as Chief Medical Officer of OnKure Therapeutics, Inc. (OKUR).

Signal8 holds 5 ownership filings by Agresta Samuel (1 Form 3, 4 Form 4), filed between Oct 8, 2024 and Aug 11, 2026. Those filings report 9 transactions, from Oct 4, 2024 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Agresta Samuel's filings is in BOULDER, CO.

Recent filings by Agresta Samuel

Aug 7, 2026: Grants or awards of OKUR derivative securities (2 lines, Form 4, code A).
Aug 7, 2026: Disposition to issuer transaction of OKUR derivative securities (Form 4, code D).
Aug 7, 2026: Grant or award of OKUR derivative securities (Form 4, code A).
Aug 7, 2026: Disposition to issuer transaction of OKUR derivative securities (Form 4, code D).
Apr 1, 2026: Grant or award of OKUR derivative securities (Form 4, code A).

Other insiders filing for OnKure Therapeutics, Inc. (OKUR)

Saccomano Nicholas A, President and CEO
Leverone Jason A., Chief Financial Officer
Manke Isaac, Director
Mathers Edward T, Director
Ratcliffe Liam, Director
Phillips Andrew John, Director

How to read Form 4 transaction codes